Literature DB >> 29666675

Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.

Arwa Z Al-Riyami1, Shahina Daar2.   

Abstract

Sickle cell disease and homozygous β-thalassaemia are common haemoglobinopathies in Oman, with many implications for local healthcare services. The transfusions of such patients take place in many hospitals throughout the country. Indications for blood transfusions require local recommendations and guidelines to ensure standardised levels of care. This article summarises existing transfusion guidelines for this group of patients and provides recommendations for blood banks and transfusion services in Oman. This information is especially pertinent to medical professionals and policy-makers developing required services for the standardised transfusion support of these patients.

Entities:  

Keywords:  Blood Banks; Blood Transfusion; Hemoglobinopathies; Oman; Sickle Cell Disease; Thalassemia Major

Mesh:

Year:  2018        PMID: 29666675      PMCID: PMC5892809          DOI: 10.18295/squmj.2018.18.01.002

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  74 in total

1.  A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.

Authors:  M Cazzola; C Borgna-Pignatti; F Locatelli; L Ponchio; Y Beguin; P De Stefano
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

2.  Red cell alloantibodies in patients with thalassemia.

Authors:  T Spanos; M Karageorga; V Ladis; J Peristeri; A Hatziliami; C Kattamis
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

3.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

4.  Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.

Authors:  D R Ambruso; J H Githens; R Alcorn; D J Dixon; L J Brown; W M Vaughn; T Hays
Journal:  Transfusion       Date:  1987 Jan-Feb       Impact factor: 3.157

5.  Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.

Authors:  Lakshmi Venkateswaran; Jun Teruya; Christy Bustillos; Donald Mahoney; Brigitta U Mueller
Journal:  Pediatr Blood Cancer       Date:  2011-02-04       Impact factor: 3.167

6.  Sickle cell morbidity profile in Omani children.

Authors:  F Jaiyesimi; R Pandey; D Bux; Y Sreekrishna; F Zaki; N Krishnamoorthy
Journal:  Ann Trop Paediatr       Date:  2002-03

7.  Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom.

Authors:  A Olujohungbe; I Hambleton; L Stephens; B Serjeant; G Serjeant
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

8.  Genetic Blood Disorders Survey in the Sultanate of Oman.

Authors:  Asya Al-Riyami; G J Ebrahim
Journal:  J Trop Pediatr       Date:  2003-07       Impact factor: 1.165

9.  Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.

Authors:  Oswaldo Castro; S Gerald Sandler; Patricia Houston-Yu; Sohail Rana
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

10.  RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients.

Authors:  Reem Ameen; Salem Al-Shemmari; Salah Al-Humood; Rafiq I Chowdhury; Ohood Al-Eyaadi; Abdulaziz Al-Bashir
Journal:  Transfusion       Date:  2003-11       Impact factor: 3.157

View more
  3 in total

1.  A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.

Authors:  Sherif M Badawy; Usman Beg; Robert I Liem; Sonali Chaudhury; Alexis A Thompson
Journal:  Blood Adv       Date:  2021-01-26

2.  International Comparison of Thalassemia Registries: Challenges and Opportunities.

Authors:  Tayebeh Noori; Marjan Ghazisaeedi; Ghasem Miri Aliabad; Yousef Mehdipour; Esmaeil Mehraeen; Rosa Conte; Reza Safdari
Journal:  Acta Inform Med       Date:  2019-03

3.  Prevalence of Hepatitis B, Hepatitis C, and HIV in Multiply Transfused Sickle Cell Disease Patients from Oman.

Authors:  Salam Alkindi; Nada Al-Umairi; Sanjay Jaju; Anil Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-11-01       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.